Initial data from 50 patients participating in a multi-center, clinical study demonstrates that Exero Medical’s xBar has the ability to reliably detect anastomotic leaks following gastrointestinal surgery at least three days earlier than the current standard of care – a potentially life-saving early alert.

Source: Journal of Surgical Research Date: July 12, 2022 Original Article: External Link The findings are the basis of a multi-center clinical trial currently ongoing at Rabin Medical Center, Sheba Medical Center, Shamir Medical Center and Kaplan Medical Center Or Yehuda, Israel, July 12, 2022 — A pre-clinical study using Exero Medical’s post-operative tissue healing […]

Diagnosis is crucial to providing efficacious healthcare. Let’s have a look at the history.

We are interviewing leaders of tech companies who are creating or have created a tech product that is helping to make a positive change in people’s lives or the environment.

Exero Medical has enrolled the first patient in its multi-center safety and feasibility study of the company’s flagship product, the xBar tissue monitoring and diagnostic system.

Curiosity and Technology Started a Company and Solved a Medical Problem with CEO Erez Shor | Ep 477

Learn about what’s new at the MEDX Xelerator LP Xelerator, including the current $1M #InterventionalOncology #MedTech Challenge.

The company’s Smart Drain technology for early detection of anastomotic leaks awarded US and Chinese patent for use of resorbable and other structures in monitoring of healing and inflammation following GI surgery.

today announced that an abstract describing its first in human data was selected for presentation at the ‘The Next Big Thing’ session of the SAGES 2021 annual meeting.

Telemedicine gains traction during the COVID-19 pandemic (Hebrew)